ABACAVIR SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Abacavir Sulfate, and what generic alternatives are available?
Abacavir Sulfate is a drug marketed by Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Apotex Inc, Cipla, Mylan Pharms Inc, Strides Pharma, Norvium Bioscience, Aurobindo Pharma, Chartwell Rx, Laurus, Teva Pharms Usa, Zydus Pharms, and Lupin Ltd. and is included in seventeen NDAs.
The generic ingredient in ABACAVIR SULFATE is abacavir sulfate; lamivudine; zidovudine. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the abacavir sulfate; lamivudine; zidovudine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ABACAVIR SULFATE?
- What are the global sales for ABACAVIR SULFATE?
- What is Average Wholesale Price for ABACAVIR SULFATE?
Summary for ABACAVIR SULFATE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 17 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Clinical Trials: | 65 |
| Patent Applications: | 2,847 |
| DailyMed Link: | ABACAVIR SULFATE at DailyMed |
Paragraph IV (Patent) Challenges for ABACAVIR SULFATE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| ZIAGEN | Oral Solution | abacavir sulfate | 20 mg/mL | 020978 | 1 | 2012-12-27 |
| ZIAGEN | Tablets | abacavir sulfate | 300 mg | 020977 | 1 | 2009-01-28 |
US Patents and Regulatory Information for ABACAVIR SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | ABACAVIR SULFATE | abacavir sulfate | SOLUTION;ORAL | 077950-001 | Mar 14, 2018 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan Pharms Inc | ABACAVIR SULFATE | abacavir sulfate | TABLET;ORAL | 091294-001 | Jun 18, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo Pharma Ltd | ABACAVIR SULFATE | abacavir sulfate | TABLET;ORAL | 077844-001 | Dec 17, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | ABACAVIR SULFATE AND LAMIVUDINE | abacavir sulfate; lamivudine | TABLET;ORAL | 204990-001 | Mar 28, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
